PET/CT in the Thorax. Pitfalls.

Radiologic Clinics of North America

Volumn 52, Issue 1, 2014, Pages 17-25

  Truong, Mylene T ^a   Viswanathan, Chitra ^a   Carter, Brett W ^a   Mawlawi, Osama ^a   Marom, Edith M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Lung cancer; PET CT; Pitfalls; Staging; Thorax

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

ARTIFACT REDUCTION; BROWN ADIPOSE TISSUE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; FALSE POSITIVE RESULT; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; GRANULATION TISSUE; HUMAN; IATROGENIC DISEASE; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; INFECTION; INFLAMMATION; ISOTOPE TRACING; LUNG CANCER; LUNG NODULE; OPTICAL RESOLUTION; PET SCANNER; PLEURODESIS; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; THORAX RADIOGRAPHY;

LUNG CANCER; PET/CT; PITFALLS; STAGING; THORAX;

ADIPOSE TISSUE, BROWN; ARTIFACTS; FALSE POSITIVE REACTIONS; HUMANS; LUNG NEOPLASMS; MULTIMODAL IMAGING; MUSCLE, STRIATED; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHY, THORACIC; THORAX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84888202779     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2013.08.005     Document Type: Review

References (32)

1. Lowe V.J., Hoffman J.M., DeLong D.M., et al. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. JNucl Med 1994, 35:1771-1776.
2. Bai C., Kinahan P.E., Brasse D., et al. An analytic study of the effects of attenuation on tumor detection in whole-body PET oncology imaging. JNucl Med 2003, 44:1855-1861.
3. Cook G.J., Wegner E.A., Fogelman I. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging. Semin Nucl Med 2004, 34:122-133.
4. Lardinois D., Weder W., Hany T.F., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. NEngl J Med 2003, 348:2500-2507.
5. Goerres G.W., Ziegler S.I., Burger C., et al. Artifacts at PET and PET/CT caused by metallic hip prosthetic material. Radiology 2003, 226:577-584.
6. Mawlawi O., Erasmus J.J., Munden R.F., et al. Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation. AJR Am J Roentgenol 2006, 186:308-319.
7. Mirzaei S., Guerchaft M., Bonnier C., et al. Use of segmented CT transmission map to avoid metal artifacts in PET images by a PET-CT device. BMC Nucl Med 2005, 5:3.
8. Nehmeh S.A., Erdi Y.E., Kalaigian H., et al. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT. JNucl Med 2003, 44:1940-1944.
9. Beyer T., Antoch G., Blodgett T., et al. Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med Mol Imaging 2003, 30:588-596.
10. Allen-Auerbach M., Yeom K., Park J., et al. Standard PET/CT of the chest during shallow breathing is inadequate for comprehensive staging of lung cancer. JNucl Med 2006, 47:298-301.
11. Pan T., Mawlawi O., Nehmeh S.A., et al. Attenuation correction of PET images with respiration-averaged CT images in PET/CT. JNucl Med 2005, 46:1481-1487.
12. Kayano T., Burant C.F., Fukumoto H., et al. Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6). JBiol Chem 1990, 265:13276-13282.
13. Pappas G.P., Olcott E.W., Drace J.E. Imaging of skeletal muscle function using (18)FDG PET: force production, activation, and metabolism. JAppl Physiol 2001, 90:329-337.
14. Goerres G.W., Von Schulthess G.K., Hany T.F. Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment. AJR Am J Roentgenol 2002, 179:1337-1343.
15. Kostakoglu L., Wong J.C., Barrington S.F., et al. Speech-related visualization of laryngeal muscles with fluorine-18-FDG. JNucl Med 1996, 37:1771-1773.
16. Kamel E.M., Goerres G.W., Burger C., et al. Recurrent laryngeal nerve palsy in patients with lung cancer: detection with PET-CT image fusion - report of six cases. Radiology 2002, 224:153-156.
17. Cohade C., Mourtzikos K.A., Wahl R.L. "USA-Fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. JNucl Med 2003, 44:1267-1270.
18. Truong M.T., Erasmus J.J., Munden R.F., et al. Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT. AJR Am J Roentgenol 2004, 183:1127-1132.
19. Gould M.K., Maclean C.C., Kuschner W.G., et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001, 285:914-924.
20. Gould M.K., Ananth L., Barnett P.G. Aclinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest 2007, 131:383-388.
21. Nomori H., Watanabe K., Ohtsuka T., et al. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer 2004, 45:19-27.
22. Higashi K., Ueda Y., Yagishita M., et al. FDG PET measurement of the proliferative potential of non-small cell lung cancer. JNucl Med 2000, 41:85-92.
23. Kubota R., Yamada S., Kubota K., et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. JNucl Med 1992, 33:1972-1980.
24. Asad S., Aquino S.L., Piyavisetpat N., et al. False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities. AJR Am J Roentgenol 2004, 182:983-989.
25. Wittram C., Scott J.A. 18F-FDG PET of pulmonary embolism. AJR Am J Roentgenol 2007, 189:171-176.
26. Schreiter N., Nogami M., Buchert R., et al. Pulmonary FDG uptake without a CT counterpart - a pitfall in interpreting PET/CT images. Acta Radiol 2011, 52:513-515.
27. Halpern B.S., Dahlbom M., Waldherr C., et al. Cardiac pacemakers and central venous lines can induce focal artifacts on CT-corrected PET images. JNucl Med 2004, 45:290-293.
28. Kwek B.H., Aquino S.L., Fischman A.J. Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest 2004, 125:2356-2360.
29. Swisher S.G., Erasmus J., Maish M. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 2004, 101:1776-1785.
30. Erdi Y.E., Macapinlac H., Rosenzweig K.E. Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med 2000, 27:861-866.
31. Truong M.T., Erasmus J.J., Macapinlac H.A., et al. Teflon injection for vocal cord paralysis: false-positive finding on FDG PET-CT in a patient with non-small cell lung cancer. AJR Am J Roentgenol 2004, 182:1587-1589.
32. Hollinger E.F., Alibazoglu H., Ali A., et al. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging. Clin Nucl Med 1998, 23:93-98.